These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 33563019)

  • 21. Post-Intracranial Hemorrhage Antithrombotic Therapy in Patients With Atrial Fibrillation.
    Lin SY; Chang YC; Lin FJ; Tang SC; Dong YH; Wang CC
    J Am Heart Assoc; 2022 Mar; 11(6):e022849. PubMed ID: 35243876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality.
    Inohara T; Xian Y; Liang L; Matsouaka RA; Saver JL; Smith EE; Schwamm LH; Reeves MJ; Hernandez AF; Bhatt DL; Peterson ED; Fonarow GC
    JAMA; 2018 Feb; 319(5):463-473. PubMed ID: 29372247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program.
    McIntyre WF; Conen D; Olshansky B; Halperin JL; Hayek E; Huisman MV; Lip GYH; Lu S; Healey JS
    Clin Cardiol; 2018 Jun; 41(6):744-751. PubMed ID: 29546729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-dependent clinical outcomes in primary versus oral anticoagulation-related intracerebral hemorrhage.
    Sprügel MI; Kuramatsu JB; Gerner ST; Sembill JA; Madžar D; Reindl C; Bobinger T; Müller T; Hoelter P; Lücking H; Engelhorn T; Huttner HB
    Int J Stroke; 2021 Jan; 16(1):83-92. PubMed ID: 31870241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiplatelet Therapy in Primary Spontaneous and Oral Anticoagulation-Associated Intracerebral Hemorrhage.
    Sprügel MI; Kuramatsu JB; Gerner ST; Sembill JA; Beuscher VD; Hagen M; Roeder SS; Lücking H; Struffert T; Dörfler A; Schwab S; Huttner HB
    Stroke; 2018 Nov; 49(11):2621-2629. PubMed ID: 30355188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology and outcomes of intracerebral hemorrhage associated with oral anticoagulation over 10 years in a population-based stroke registry.
    Gabriele F; Foschi M; Conversi F; Ciuffini D; De Santis F; Orlandi B; De Santis F; Ornello R; Sacco S
    Int J Stroke; 2024 Jun; 19(5):515-525. PubMed ID: 37997897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage: Extended Follow-up of the RESTART Randomized Clinical Trial.
    Al-Shahi Salman R; Dennis MS; Sandercock PAG; Sudlow CLM; Wardlaw JM; Whiteley WN; Murray GD; Stephen J; Rodriguez A; Lewis S; Werring DJ; White PM;
    JAMA Neurol; 2021 Oct; 78(10):1179-1186. PubMed ID: 34477823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal Treatment in Oral Anticoagulant-Related Intracerebral Hemorrhage-An Observational Study Based on the Swedish Stroke Register.
    Apostolaki-Hansson T; Ullberg T; Pihlsgård M; Norrving B; Petersson J
    Front Neurol; 2020; 11():760. PubMed ID: 32903832
    [No Abstract]   [Full Text] [Related]  

  • 29. Outcome of intracerebral hemorrhage associated with different oral anticoagulants.
    Wilson D; Seiffge DJ; Traenka C; Basir G; Purrucker JC; Rizos T; Sobowale OA; Sallinen H; Yeh SJ; Wu TY; Ferrigno M; Houben R; Schreuder FHBM; Perry LA; Tanaka J; Boulanger M; Al-Shahi Salman R; Jäger HR; Ambler G; Shakeshaft C; Yakushiji Y; Choi PMC; Staals J; Cordonnier C; Jeng JS; Veltkamp R; Dowlatshahi D; Engelter ST; Parry-Jones AR; Meretoja A; Werring DJ;
    Neurology; 2017 May; 88(18):1693-1700. PubMed ID: 28381513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-ICH warfarin use, not antiplatelets, increased case fatality in spontaneous ICH patients.
    Chen YW; Tang SC; Tsai LK; Yeh SJ; Chiou HY; Yip PK; Jeng JS
    Eur J Neurol; 2013 Aug; 20(8):1128-34. PubMed ID: 22897602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality in patients with intracerebral hemorrhage associated with antiplatelet agents, oral anticoagulants or no antithrombotic therapy.
    Franco L; Paciaroni M; Enrico ML; Scoditti U; Guideri F; Chiti A; De Vito A; Terruso V; Consoli D; Vanni S; Giossi A; Manina G; Nitti C; Re R; Sacco S; Cappelli R; Beyer-Westendorf J; Pomero F; Agnelli G; Becattini C
    Eur J Intern Med; 2020 May; 75():35-43. PubMed ID: 31955918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood Pressure and Anticoagulation Reversal Management during Off-Hours in Oral Anticoagulation-Associated Intracerebral Hemorrhage.
    Mrochen A; Sprügel MI; Gerner ST; Sembill JA; Lang S; Lücking H; Kuramatsu JB; Huttner HB
    Cerebrovasc Dis; 2020; 49(2):177-184. PubMed ID: 32320990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mortality in patients with intracerebral haemorrhage associated with oral anticoagulation. Efficacy of a reversal protocol and clinical follow-up (ICH-OAC project)].
    Amores-Valenciano P; Ruiz Escribano-Taravilla E; Romero-Sánchez CM; Prado-Mira A; García-Gil E; Espejo-López AB; Collado-Jiménez RM; Molina-Nuevo JD; Marín-Sánchez A; Hernández-Fernández F
    Rev Neurol; 2021 Sep; 73(5):165-173. PubMed ID: 34328205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes in Antiplatelet-Associated Intracerebral Hemorrhage in the TICH-2 Randomized Controlled Trial.
    Law ZK; Desborough M; Roberts I; Al-Shahi Salman R; England TJ; Werring DJ; Robinson T; Krishnan K; Dineen R; Laska AC; Peters N; Egea-Guerrero JJ; Karlinski M; Christensen H; Roffe C; Bereczki D; Ozturk S; Thanabalan J; Collins R; Beridze M; Bath PM; Sprigg N
    J Am Heart Assoc; 2021 Feb; 10(5):e019130. PubMed ID: 33586453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracerebral hemorrhage during anticoagulation with vitamin K antagonists: a consecutive observational study.
    Horstmann S; Rizos T; Lauseker M; Möhlenbruch M; Jenetzky E; Hacke W; Steiner T; Veltkamp R
    J Neurol; 2013 Aug; 260(8):2046-51. PubMed ID: 23645221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracerebral bleeding in patients on antithrombotic agents.
    Veltkamp R; Rizos T; Horstmann S
    Semin Thromb Hemost; 2013 Nov; 39(8):963-71. PubMed ID: 24114010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How do anticoagulated atrial fibrillation patients who suffer ischemic stroke or spontaneous intracerebral hemorrhage differ?
    Lehtola H; Hartikainen J; Hartikainen P; Kiviniemi T; Nuotio I; Palomäki A; Ylitalo A; Airaksinen KEJ; Mustonen P
    Clin Cardiol; 2018 May; 41(5):608-614. PubMed ID: 29745996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initiating anticoagulant therapy after ICH is associated with patient characteristics and treatment recommendations.
    Sembill JA; Wieser CY; Sprügel MI; Gerner ST; Giede-Jeppe A; Reindl C; Eyüpoglu IY; Hoelter P; Lücking H; Kuramatsu JB; Huttner HB
    J Neurol; 2018 Oct; 265(10):2404-2414. PubMed ID: 30128711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiplatelet Agent Use After Stroke due to Intracerebral Hemorrhage.
    Al-Shahi Salman R; Greenberg SM
    Stroke; 2023 Dec; 54(12):3173-3181. PubMed ID: 37916459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prior oral antithrombotic therapy is associated with early death in patients with supratentorial intracerebral hemorrhage.
    Yamashita S; Kimura K; Iguchi Y; Shibazaki K
    Intern Med; 2011; 50(5):413-9. PubMed ID: 21372450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.